Compare key investment metrics of 304360 and 메타케어 in real time. Both stocks belong to the 줄기세포 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- By market capitalization, 304360 is larger — ₩255B vs 메타케어's ₩29B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 304360's current price of 20,550원 sits at about 10% of its 52-week range (17,930원–44,000원).
- 메타케어's current price of 1,317원 sits at about 10% of its 52-week range (1,001원–4,090원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 304360 | 메타케어 |
|---|---|---|
| Price | 20,550원 | 1,317원 |
| PER | - | 24.39배 |
| PBR | 31배 | 0.19배 |
| Market Cap | ₩255B | ₩29B |
| 52-Week High | 44,000원 | 4,090원 |
| 52-Week Low | 17,930원 | 1,001원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 304360 or 메타케어?
PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share. A lower PER may suggest the stock is undervalued relative to its earnings. Since PER changes with each earnings report, check the real-time comparison table on this page for the latest 304360 and 메타케어 PER values.
What is the dividend yield difference between 304360 and 메타케어?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 304360 and 메타케어 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 304360 and 메타케어?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.